{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:06:27Z","timestamp":1788444387638,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009054","name":"U.S. President\u2019s Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","award":["NCT03762382"],"award-info":[{"award-number":["NCT03762382"]}],"id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009054","name":"U.S. President\u2019s Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","award":["U01PS005183"],"award-info":[{"award-number":["U01PS005183"]}],"id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013965","name":"Eastern Virginia Medical School","doi-asserted-by":"publisher","award":["AID-OAA-A-14-00010"],"award-info":[{"award-number":["AID-OAA-A-14-00010"]}],"id":[{"id":"10.13039\/100013965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013965","name":"Eastern Virginia Medical School","doi-asserted-by":"publisher","award":["AID-OAA-A-14-00011"],"award-info":[{"award-number":["AID-OAA-A-14-00011"]}],"id":[{"id":"10.13039\/100013965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cct.2022.106935","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:02:09Z","timestamp":1663938129000},"page":"106935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019"],"prefix":"10.1016","volume":"122","author":[{"given":"Eleanor","family":"McLellan-Lemal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie R.","family":"Deaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua E.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ondenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Mudhune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Nyagol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo F.","family":"Doncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon A.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Heffron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly R.","family":"Mugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.cct.2022.106935_bb0005","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.antiviral.2013.09.019","article-title":"Lessons from reproductive health to inform multipurpose prevention technologies: don\u2019t reinvent the wheel","volume":"100","author":"Brady","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.cct.2022.106935_bb0010","series-title":"MPT Product Development Database","author":"Coalition Advancing Multipurpose Innovations (CAMI)","year":"2022"},{"issue":"6","key":"10.1016\/j.cct.2022.106935_bb0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1410649","article-title":"Tenofovir gel for the prevention of herpes simplex virus type 2 infection","volume":"373","author":"Abdool Karim","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2022.106935_bb0020","author":"El-Sahn"},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0000000000000207","article-title":"Tenofovir-based oral PrEP prevents HIV infection among women","volume":"11","author":"Thomson","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"9","key":"10.1016\/j.cct.2022.106935_bb0030","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1089\/jwh.2018.7353","article-title":"Factors affecting pre-exposure prophylaxis implementation for women in the United States: a systematic review","volume":"28","author":"Bradley","year":"2019","journal-title":"J. Women\u2019s Health"},{"issue":"6","key":"10.1016\/j.cct.2022.106935_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198680","article-title":"Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: a systematic literature review","volume":"13","author":"Warren","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cct.2022.106935_bb0040","series-title":"Rosenberg, Z for the IPM 027\/The ring study research center teams. Safety and efficacy of dapivirine vaginal ring for HIV-1 prevention in African women (Abstract #110LB)","author":"Nel","year":"2016"},{"key":"10.1016\/j.cct.2022.106935_bb0045","series-title":"Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women","author":"World Health Organization (WHO)","year":"2022"},{"issue":"2","key":"10.1016\/j.cct.2022.106935_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40271-020-00486-9","article-title":"Eliciting preferences for HIV prevention technologies: a systematic review","volume":"14","author":"Beckham","year":"2021","journal-title":"Patient"},{"issue":"11","key":"10.1016\/j.cct.2022.106935_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224898","article-title":"Vaginal ring acceptability and related preferences among women in low- and middle-income countries: a systematic review and narrative synthesis","volume":"14","author":"Griffin","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cct.2022.106935_bb0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.chom.2020.03.020","article-title":"PrEP for HIV prevention: evidence, global scale-up, and emerging options","volume":"27","author":"Celum","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12977-018-0408-3","article-title":"Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: can it change the game?","volume":"15","author":"Eakle","year":"2018","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/COH.0000000000000221","article-title":"Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception","volume":"11","author":"Delany-Moretlwe","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"6","key":"10.1016\/j.cct.2022.106935_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.contraception.2018.01.007","article-title":"Family planning providers\u2019 role in offering PrEP to women","volume":"97","author":"Seidman","year":"2018","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.cct.2022.106935_bb0080","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1007\/s10461-021-03205-z","article-title":"Acceptability of the dapivirine vaginal ring for HIV-1 prevention and association with adherence in a phase III trial","volume":"25","author":"Mayo","year":"2021","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2022.106935_bb0085","series-title":"Phenomenological research methods","author":"Moustakas","year":"1994"},{"key":"10.1016\/j.cct.2022.106935_bb0090","series-title":"Researching lived experience: Human science for an action sensitive pedagogy","author":"van Manen","year":"1990"},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0095","article-title":"Performance of a validated risk score to predict HIV-1 acquisition among African women participating in a trial of the dapivirine vaginal ring","volume":"77","author":"Balkus","year":"2018","journal-title":"JAIDS"},{"issue":"2","key":"10.1016\/j.cct.2022.106935_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1525822X980100020301","article-title":"Codebook development for team-based qualitative analysis","volume":"10","author":"MacQueen","year":"1998","journal-title":"Cam. J."},{"issue":"2","key":"10.1016\/j.cct.2022.106935_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual. Res. Psychol."},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.cct.2022.106935_bb0115","series-title":"Applied Qualitative Research Design: A Total Quality Framework Approach","author":"Roller","year":"2015"},{"key":"10.1016\/j.cct.2022.106935_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.colegn.2011.09.006","article-title":"Factors that affect acceptance of HIV microbicides among women","volume":"19","author":"Domanska","year":"2012","journal-title":"Collegian"},{"key":"10.1016\/j.cct.2022.106935_bb0125","first-page":"1231","article-title":"Microbicides in the prevention of HIV infection","volume":"70","author":"Nuttall","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.cct.2022.106935_bb0130","doi-asserted-by":"crossref","first-page":"19159","DOI":"10.7448\/IAS.17.3.19159","article-title":"(2014), engaging male partners in women\u2019s microbicide use: evidence from clinical trials and implications for future research and microbicide introduction","volume":"17","author":"Lanham","year":"2014","journal-title":"J. Int. AIDS Soc."},{"issue":"5","key":"10.1016\/j.cct.2022.106935_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25283","article-title":"End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro clinical crossover study","volume":"22","author":"Montgomery","year":"2019","journal-title":"J. Int. AIDS Soc."},{"issue":"8","key":"10.1016\/j.cct.2022.106935_bb0140","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","article-title":"Acceptability and use of a dapivirine vaginal ring in a phase III trial","volume":"31","author":"Montgomery","year":"2017","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.cct.2022.106935_bb0145","first-page":"304","article-title":"First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring","volume":"81","author":"van der Straten","year":"2019","journal-title":"JAIDS"},{"issue":"2","key":"10.1016\/j.cct.2022.106935_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10461-017-1962-8","article-title":"Acceptability of a tenofovir disoproxil fumarate vaginal ring for HIV prevention among women in new York City","volume":"22","author":"Watnick","year":"2018","journal-title":"AIDS Behav."},{"issue":"11","key":"10.1016\/j.cct.2022.106935_bb0155","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s10461-016-1299-8","article-title":"Adherence and acceptability of a multidrug vaginal ving for HIV prevention in a phase I study in the United States","volume":"20","author":"van der Straten","year":"2016","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2022.106935_bb0160","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1038\/s41598-022-13475-9","article-title":"Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya","volume":"12","author":"Dabee","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cct.2022.106935_bb0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/13625187.2013.801954","article-title":"Vaginal health in contraceptive vaginal ring users\u2013a review","volume":"18","author":"Lete","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.cct.2022.106935_bb0170","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.healthplace.2012.04.006","article-title":"The influence of perceptions of community norms on current contraceptive use among men and women in Ethiopia and Kenya","volume":"18","author":"Dynes","year":"2012","journal-title":"Health Place"},{"key":"10.1016\/j.cct.2022.106935_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2307\/2950781","article-title":"Husband-wife communication about family planning and contraceptive use in Kenya","volume":"23","author":"Lasee","year":"1997","journal-title":"Int. Fam. Plan. Perspect."},{"issue":"11","key":"10.1016\/j.cct.2022.106935_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241506","article-title":"Use of long-acting reversible contraception among adolescents and young women in Kenya","volume":"15","author":"Kungu","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cct.2022.106935_bb0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/13625187.2012.700744","article-title":"Intrauterine contraception for nulliparous women: translating research into action (INTRA) group. A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women","volume":"17","author":"Black","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12889-015-1483-1","article-title":"Barriers to modern contraceptive methods uptake among young women in Kenya: a qualitative study","volume":"15","author":"Ochako","year":"2015","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.cct.2022.106935_bb0195","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Oral tenofovir-based HIV pre-exposure prophylaxis (PrEP) for all populations: a systematic review and meta-analysis of effectiveness, safety, behavioural, and reproductive health outcomes","volume":"30","author":"Fonner","year":"2016","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-021-11375-7","article-title":"Prevalence and factors associated with covert contraceptive use in Kenya: a cross-sectional study","volume":"21","author":"Akoth","year":"2021","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.cct.2022.106935_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0272684X16685254","article-title":"Factors influencing contraceptive use in sub-Saharan Africa: a systematic review","volume":"37","author":"Blackstone","year":"2017","journal-title":"Int. Q. Commun. Health Educ."},{"key":"10.1016\/j.cct.2022.106935_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-08977-y","article-title":"Covert use of contraception in three sub-Saharan African countries: a qualitative exploration of motivations and challenges","volume":"20","author":"Kibira","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.cct.2022.106935_bb0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00224490802398407","article-title":"Young women\u2019s use of a vaginal microbicide surrogate: the role of individual and contextual factors in acceptability and sexual pleasure","volume":"46","author":"Tanner","year":"2009","journal-title":"J. Sex Res."},{"issue":"2","key":"10.1016\/j.cct.2022.106935_bb0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10810730.2017.1421728","article-title":"\u201cMy body. My choice\u201d: a qualitative study of the influence of trust and locus of control on postpartum contraceptive choice","volume":"23","author":"Sundstrom","year":"2018","journal-title":"J. Health Commun."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422002610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422002610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:58:06Z","timestamp":1761555486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714422002610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":44,"alternative-id":["S1551714422002610"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2022.106935","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2022.106935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106935"}}